French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR
Launched by PARIS SUDDEN DEATH EXPERTISE CENTER · Dec 16, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The FOREVER cohort study is a clinical trial focused on a new type of heart device called the extravascular cardioverter-defibrillator (EV-ICD). This device is designed to help prevent sudden cardiac death in patients at high risk due to heart rhythm problems. The EV-ICD is different from traditional devices because it is implanted in a way that may offer better safety and effectiveness. The trial aims to gather information on how well the EV-ICD works in real-world settings across France, looking at its long-term safety and effectiveness after implantation.
To participate in this study, patients must be undergoing an EV-ICD implantation. There are no specific age or gender restrictions, but individuals who do not agree to participate will be excluded. If you join the study, you can expect to have your device implanted and then be monitored over time to see how it performs. This study is important because it will help doctors understand more about this innovative device and its impact on patients’ health in the long run.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients undergoing EV-ICD implantation
- Exclusion Criteria:
- • Refusal of consent
About Paris Sudden Death Expertise Center
The Paris Sudden Death Expertise Center is a leading clinical research organization dedicated to advancing the understanding and prevention of sudden cardiac death. Situated at the forefront of cardiovascular research, the center focuses on innovative clinical trials and expert analyses to identify risk factors, improve diagnostic methods, and develop effective interventions. With a multidisciplinary team of renowned cardiologists, researchers, and healthcare professionals, the center aims to enhance patient outcomes through rigorous scientific inquiry and collaboration with academic institutions and healthcare providers. Its commitment to excellence in research and patient care positions the Paris Sudden Death Expertise Center as a pivotal contributor to the global fight against sudden cardiac events.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported